首页
数据库
关于我们
联系我们
您当前的位置： 首页 > 数据库
所属年份
2008 2017 2018 2019 2020 2021 2022 2023 2024
到
2008 2017 2018 2019 2020 2021 2022 2023 2024
检索 清除
手术分类
  • 全部（1880）
  • 腹部手术（323）
  • 胸科手术（41）
  • 血管手术（5）
  • 心脏手术（56）
  • 神经外科（4）
  • 头颈部（35）
  • 骨科（78）
  • 泌尿外科（0）
  • 妇产手术（56）
  • 日间手术（26）
  • 手术室外（0）
  • 创伤和烧伤（0）
  • 非心脏手术（410）
  • 老年（0）
  • 小儿新生儿（126）
  • 特殊患者（42）
  • 未说明手术类型（678）
阶段管理
  • 术前宣教（21）
  • 术前评估（33）
  • 术前用药（15）
  • 术前禁食水（12）
  • 麻醉选择（21）
  • 麻醉用药（10）
  • 术中监测（23）
  • 液体管理（14）
  • 血液保护（3）
  • 体温管理（8）
  • 术后疼痛（43）
  • POD（8）
  • PONV（10）
  • 术后康复（50）
  • 特殊情况（43）
  • 术前肠道准备（9）
排序：
发表时间 阅读量
Array ( [id] => 1322 [catid] => 297 [title] => Management of severe peri-operative bleeding: Guidelines from the European Society of Anaesthesiology and Intensive Care [thumb] => [keywords] => [description] => [hits] => [uid] => 1 [author] => 系统管理员 [status] => 9 [url] => https://www.anes-guide.com/show/1322.html [link_id] => 0 [tableid] => 0 [inputip] => 14.105.95.222 [inputtime] => 2024-01-11 15:24:29 [updatetime] => 2024-01-11 15:24:29 [displayorder] => 0 [nrjc] => Array ( ) [nrsh] => Array ( ) [xzl] => 0 [dzl] => 0 [wailian] => https://pubmed.ncbi.nlm.nih.gov/36855941/ [demo_url] => [zjpjff] => GRADE [zjfj] => [tjqd] => [nianfen] => 2023 [guojia] => the European Society of Anaesthesiology and Intens [pdf] => [tjyjyw] => [lyyw] => The osteosynthesis technique of proximal endomedullary nailing may reduce blood loss in trochanteric femur fracture. （Evidence level: moderate；Recommendation grade: strong） [laiyuan] => 近端髓内钉技术可减少股骨粗隆骨折的失血量。（证据级别：中；推荐强度：强推荐） [znzldj] => B [_inputtime] => 1704957869 [_updatetime] => 1704957869 [_nrjc] => [_nrsh] => )
推荐意见
近端髓内钉技术可减少股骨粗隆骨折的失血量。（证据级别：中；推荐强度：强推荐）

The osteosynthesis technique of proximal endomedullary nailing may reduce blood loss in trochanteric femur fracture. （Evidence level: moderate；Recommendation grade: strong）

证据评价方法：GRADE

指南质量等级：B

年份：2023

国家：the European Society of Anaesthesiology and Intens

来源 Management of severe peri-operative bleeding: Guidelines from the European Society of Anaesthesiology and Intensive Care
原文链接
阅读
Array ( [id] => 1323 [catid] => 297 [title] => Management of severe peri-operative bleeding: Guidelines from the European Society of Anaesthesiology and Intensive Care [thumb] => [keywords] => [description] => [hits] => [uid] => 1 [author] => 系统管理员 [status] => 9 [url] => https://www.anes-guide.com/show/1323.html [link_id] => 0 [tableid] => 0 [inputip] => 14.105.95.222 [inputtime] => 2024-01-11 15:24:29 [updatetime] => 2024-01-11 15:24:29 [displayorder] => 0 [nrjc] => Array ( ) [nrsh] => Array ( ) [xzl] => 0 [dzl] => 0 [wailian] => https://pubmed.ncbi.nlm.nih.gov/36855941/ [demo_url] => [zjpjff] => GRADE [zjfj] => [tjqd] => [nianfen] => 2023 [guojia] => the European Society of Anaesthesiology and Intens [pdf] => [tjyjyw] => [lyyw] => We suggest the maintenance of restrictive transfusion thresholds in the management of hip fracture. （Evidence level: low；Recommendation grade: weak） [laiyuan] => 我们建议在髋部骨折的治疗中维持限制性输血阈值。（证据级别：低；推荐强度：弱推荐） [znzldj] => B [_inputtime] => 1704957869 [_updatetime] => 1704957869 [_nrjc] => [_nrsh] => )
推荐意见
我们建议在髋部骨折的治疗中维持限制性输血阈值。（证据级别：低；推荐强度：弱推荐）

We suggest the maintenance of restrictive transfusion thresholds in the management of hip fracture. （Evidence level: low；Recommendation grade: weak）

证据评价方法：GRADE

指南质量等级：B

年份：2023

国家：the European Society of Anaesthesiology and Intens

来源 Management of severe peri-operative bleeding: Guidelines from the European Society of Anaesthesiology and Intensive Care
原文链接
阅读
Array ( [id] => 1280 [catid] => 297 [title] => Management of severe peri-operative bleeding: Guidelines from the European Society of Anaesthesiology and Intensive Care [thumb] => [keywords] => [description] => [hits] => [uid] => 1 [author] => 系统管理员 [status] => 9 [url] => https://www.anes-guide.com/show/1280.html [link_id] => 0 [tableid] => 0 [inputip] => 14.105.95.222 [inputtime] => 2024-01-11 15:24:28 [updatetime] => 2024-01-11 15:24:28 [displayorder] => 0 [nrjc] => Array ( ) [nrsh] => Array ( ) [xzl] => 0 [dzl] => 0 [wailian] => https://pubmed.ncbi.nlm.nih.gov/36855941/ [demo_url] => [zjpjff] => GRADE [zjfj] => [tjqd] => [nianfen] => 2023 [guojia] => the European Society of Anaesthesiology and Intens [pdf] => [tjyjyw] => [lyyw] => We recommend replacement/substitution therapy with factor concentrates, either plasma-derived or recombinant products, for major bleeding/surgery in patients with von Willebrand disease (VWD) or haemophilia A and B. （Evidence level: low；Recommendation grade: strong） [laiyuan] => 对于冯-威廉氏病（VWD）或 A 型和 B 型血友病患者的大出血/手术，我们建议使用血浆浓缩因子或重组产品进行替代/替换治疗。（证据级别：低；推荐强度：强推荐） [znzldj] => B [_inputtime] => 1704957868 [_updatetime] => 1704957868 [_nrjc] => [_nrsh] => )
推荐意见
对于冯-威廉氏病（VWD）或 A 型和 B 型血友病患者的大出血/手术，我们建议使用血浆浓缩因子或重组产品进行替代/替换治疗。（证据级别：低；推荐强度：强推荐）

We recommend replacement/substitution therapy with factor concentrates, either plasma-derived or recombinant products, for major bleeding/surgery in patients with von Willebrand disease (VWD) or haemophilia A and B. （Evidence level: low；Recommendation grade: strong）

证据评价方法：GRADE

指南质量等级：B

年份：2023

国家：the European Society of Anaesthesiology and Intens

来源 Management of severe peri-operative bleeding: Guidelines from the European Society of Anaesthesiology and Intensive Care
原文链接
阅读
Array ( [id] => 1281 [catid] => 297 [title] => Management of severe peri-operative bleeding: Guidelines from the European Society of Anaesthesiology and Intensive Care [thumb] => [keywords] => [description] => [hits] => [uid] => 1 [author] => 系统管理员 [status] => 9 [url] => https://www.anes-guide.com/show/1281.html [link_id] => 0 [tableid] => 0 [inputip] => 14.105.95.222 [inputtime] => 2024-01-11 15:24:28 [updatetime] => 2024-01-11 15:24:28 [displayorder] => 0 [nrjc] => Array ( ) [nrsh] => Array ( ) [xzl] => 0 [dzl] => 0 [wailian] => https://pubmed.ncbi.nlm.nih.gov/36855941/ [demo_url] => [zjpjff] => GRADE [zjfj] => [tjqd] => [nianfen] => 2023 [guojia] => the European Society of Anaesthesiology and Intens [pdf] => [tjyjyw] => [lyyw] => We suggest peri-operative antifibrinolytics as adjunct therapy in patients with haemophilia or VWD. （Evidence level: moderate；Recommendation grade: weak） [laiyuan] => 我们建议将围手术期抗纤维蛋白溶解剂作为血友病或冯-威廉氏病患者的辅助疗法。 （证据级别：中；推荐强度：弱推荐） [znzldj] => B [_inputtime] => 1704957868 [_updatetime] => 1704957868 [_nrjc] => [_nrsh] => )
推荐意见
我们建议将围手术期抗纤维蛋白溶解剂作为血友病或冯-威廉氏病患者的辅助疗法。 （证据级别：中；推荐强度：弱推荐）

We suggest peri-operative antifibrinolytics as adjunct therapy in patients with haemophilia or VWD. （Evidence level: moderate；Recommendation grade: weak）

证据评价方法：GRADE

指南质量等级：B

年份：2023

国家：the European Society of Anaesthesiology and Intens

来源 Management of severe peri-operative bleeding: Guidelines from the European Society of Anaesthesiology and Intensive Care
原文链接
阅读
Array ( [id] => 1282 [catid] => 297 [title] => Management of severe peri-operative bleeding: Guidelines from the European Society of Anaesthesiology and Intensive Care [thumb] => [keywords] => [description] => [hits] => [uid] => 1 [author] => 系统管理员 [status] => 9 [url] => https://www.anes-guide.com/show/1282.html [link_id] => 0 [tableid] => 0 [inputip] => 14.105.95.222 [inputtime] => 2024-01-11 15:24:28 [updatetime] => 2024-01-11 15:24:28 [displayorder] => 0 [nrjc] => Array ( ) [nrsh] => Array ( ) [xzl] => 0 [dzl] => 0 [wailian] => https://pubmed.ncbi.nlm.nih.gov/36855941/ [demo_url] => [zjpjff] => GRADE [zjfj] => [tjqd] => [nianfen] => 2023 [guojia] => the European Society of Anaesthesiology and Intens [pdf] => [tjyjyw] => [lyyw] => We suggest that rFVIIa be considered in patients with Glanzmann thrombasthenia undergoing surgery. （Evidence level: low；Recommendation grade: weak） [laiyuan] => 我们建议格兰茨曼血栓形成症患者在接受手术时考虑使用 rFVIIa。 （证据级别：低；推荐强度：弱推荐） [znzldj] => B [_inputtime] => 1704957868 [_updatetime] => 1704957868 [_nrjc] => [_nrsh] => )
推荐意见
我们建议格兰茨曼血栓形成症患者在接受手术时考虑使用 rFVIIa。 （证据级别：低；推荐强度：弱推荐）

We suggest that rFVIIa be considered in patients with Glanzmann thrombasthenia undergoing surgery. （Evidence level: low；Recommendation grade: weak）

证据评价方法：GRADE

指南质量等级：B

年份：2023

国家：the European Society of Anaesthesiology and Intens

来源 Management of severe peri-operative bleeding: Guidelines from the European Society of Anaesthesiology and Intensive Care
原文链接
阅读
Array ( [id] => 1283 [catid] => 297 [title] => Management of severe peri-operative bleeding: Guidelines from the European Society of Anaesthesiology and Intensive Care [thumb] => [keywords] => [description] => [hits] => [uid] => 1 [author] => 系统管理员 [status] => 9 [url] => https://www.anes-guide.com/show/1283.html [link_id] => 0 [tableid] => 0 [inputip] => 14.105.95.222 [inputtime] => 2024-01-11 15:24:28 [updatetime] => 2024-01-11 15:24:28 [displayorder] => 0 [nrjc] => Array ( ) [nrsh] => Array ( ) [xzl] => 0 [dzl] => 0 [wailian] => https://pubmed.ncbi.nlm.nih.gov/36855941/ [demo_url] => [zjpjff] => GRADE [zjfj] => [tjqd] => [nianfen] => 2023 [guojia] => the European Society of Anaesthesiology and Intens [pdf] => [tjyjyw] => [lyyw] => We suggest that rFVIIa be used in peri-operative bleeding because of inherited factor VII deficiency. （Evidence level: low；Recommendation grade: weak） [laiyuan] => 我们建议在因遗传性 VII 因子缺乏症导致围手术期出血时使用 rFVIIa。（证据级别：低；推荐强度：弱推荐） [znzldj] => B [_inputtime] => 1704957868 [_updatetime] => 1704957868 [_nrjc] => [_nrsh] => )
推荐意见
我们建议在因遗传性 VII 因子缺乏症导致围手术期出血时使用 rFVIIa。（证据级别：低；推荐强度：弱推荐）

We suggest that rFVIIa be used in peri-operative bleeding because of inherited factor VII deficiency. （Evidence level: low；Recommendation grade: weak）

证据评价方法：GRADE

指南质量等级：B

年份：2023

国家：the European Society of Anaesthesiology and Intens

来源 Management of severe peri-operative bleeding: Guidelines from the European Society of Anaesthesiology and Intensive Care
原文链接
阅读
Array ( [id] => 1284 [catid] => 297 [title] => Management of severe peri-operative bleeding: Guidelines from the European Society of Anaesthesiology and Intensive Care [thumb] => [keywords] => [description] => [hits] => [uid] => 1 [author] => 系统管理员 [status] => 9 [url] => https://www.anes-guide.com/show/1284.html [link_id] => 0 [tableid] => 0 [inputip] => 14.105.95.222 [inputtime] => 2024-01-11 15:24:28 [updatetime] => 2024-01-11 15:24:28 [displayorder] => 0 [nrjc] => Array ( ) [nrsh] => Array ( ) [xzl] => 0 [dzl] => 0 [wailian] => https://pubmed.ncbi.nlm.nih.gov/36855941/ [demo_url] => [zjpjff] => GRADE [zjfj] => [tjqd] => [nianfen] => 2023 [guojia] => the European Society of Anaesthesiology and Intens [pdf] => [tjyjyw] => [lyyw] => We recommend against major elective surgery in patients with COVID-19 coagulopathy.（Evidence level: low；Recommendation grade: strong） [laiyuan] => 我们建议患有新冠肺炎凝血功能障碍的患者不要进行大型择期手术。（证据级别：低；推荐强度：强推荐） [znzldj] => B [_inputtime] => 1704957868 [_updatetime] => 1704957868 [_nrjc] => [_nrsh] => )
推荐意见
我们建议患有新冠肺炎凝血功能障碍的患者不要进行大型择期手术。（证据级别：低；推荐强度：强推荐）

We recommend against major elective surgery in patients with COVID-19 coagulopathy.（Evidence level: low；Recommendation grade: strong）

证据评价方法：GRADE

指南质量等级：B

年份：2023

国家：the European Society of Anaesthesiology and Intens

来源 Management of severe peri-operative bleeding: Guidelines from the European Society of Anaesthesiology and Intensive Care
原文链接
阅读
Array ( [id] => 1285 [catid] => 297 [title] => Management of severe peri-operative bleeding: Guidelines from the European Society of Anaesthesiology and Intensive Care [thumb] => [keywords] => [description] => [hits] => [uid] => 1 [author] => 系统管理员 [status] => 9 [url] => https://www.anes-guide.com/show/1285.html [link_id] => 0 [tableid] => 0 [inputip] => 14.105.95.222 [inputtime] => 2024-01-11 15:24:28 [updatetime] => 2024-01-11 15:24:28 [displayorder] => 0 [nrjc] => Array ( ) [nrsh] => Array ( ) [xzl] => 0 [dzl] => 0 [wailian] => https://pubmed.ncbi.nlm.nih.gov/36855941/ [demo_url] => [zjpjff] => GRADE [zjfj] => [tjqd] => [nianfen] => 2023 [guojia] => the European Society of Anaesthesiology and Intens [pdf] => [tjyjyw] => [lyyw] => In (semi)urgent surgery in patients with COVID-19 coagulopathy, we suggest avoiding prophylactic TXA administration.（Evidence level: low；Recommendation grade: weak） [laiyuan] => 在（半）紧急手术的新冠肺炎凝血障碍患者中，我们建议避免预防性应用氨甲环酸。（证据级别：低；推荐强度：弱推荐） [znzldj] => B [_inputtime] => 1704957868 [_updatetime] => 1704957868 [_nrjc] => [_nrsh] => )
推荐意见
在（半）紧急手术的新冠肺炎凝血障碍患者中，我们建议避免预防性应用氨甲环酸。（证据级别：低；推荐强度：弱推荐）

In (semi)urgent surgery in patients with COVID-19 coagulopathy, we suggest avoiding prophylactic TXA administration.（Evidence level: low；Recommendation grade: weak）

证据评价方法：GRADE

指南质量等级：B

年份：2023

国家：the European Society of Anaesthesiology and Intens

来源 Management of severe peri-operative bleeding: Guidelines from the European Society of Anaesthesiology and Intensive Care
原文链接
阅读
Array ( [id] => 1286 [catid] => 297 [title] => Management of severe peri-operative bleeding: Guidelines from the European Society of Anaesthesiology and Intensive Care [thumb] => [keywords] => [description] => [hits] => [uid] => 1 [author] => 系统管理员 [status] => 9 [url] => https://www.anes-guide.com/show/1286.html [link_id] => 0 [tableid] => 0 [inputip] => 14.105.95.222 [inputtime] => 2024-01-11 15:24:28 [updatetime] => 2024-01-11 15:24:28 [displayorder] => 0 [nrjc] => Array ( ) [nrsh] => Array ( ) [xzl] => 0 [dzl] => 0 [wailian] => https://pubmed.ncbi.nlm.nih.gov/36855941/ [demo_url] => [zjpjff] => GRADE [zjfj] => [tjqd] => [nianfen] => 2023 [guojia] => the European Society of Anaesthesiology and Intens [pdf] => [tjyjyw] => [lyyw] => We suggest VHA-guided, goal-directed procoagulant treatment of peri-operatively acquired coagulopathic bleeding avoiding overcorrection.（Evidence level: low；Recommendation grade: weak） [laiyuan] => 我们建议在粘黏弹性止血试验的引导下，围手术期获得性凝血性出血以目标为导向的凝血治疗，以避免过度矫正。（证据级别：低；推荐强度：弱推荐） [znzldj] => B [_inputtime] => 1704957868 [_updatetime] => 1704957868 [_nrjc] => [_nrsh] => )
推荐意见
我们建议在粘黏弹性止血试验的引导下，围手术期获得性凝血性出血以目标为导向的凝血治疗，以避免过度矫正。（证据级别：低；推荐强度：弱推荐）

We suggest VHA-guided, goal-directed procoagulant treatment of peri-operatively acquired coagulopathic bleeding avoiding overcorrection.（Evidence level: low；Recommendation grade: weak）

证据评价方法：GRADE

指南质量等级：B

年份：2023

国家：the European Society of Anaesthesiology and Intens

来源 Management of severe peri-operative bleeding: Guidelines from the European Society of Anaesthesiology and Intensive Care
原文链接
阅读
Array ( [id] => 1287 [catid] => 297 [title] => Management of severe peri-operative bleeding: Guidelines from the European Society of Anaesthesiology and Intensive Care [thumb] => [keywords] => [description] => [hits] => [uid] => 1 [author] => 系统管理员 [status] => 9 [url] => https://www.anes-guide.com/show/1287.html [link_id] => 0 [tableid] => 0 [inputip] => 14.105.95.222 [inputtime] => 2024-01-11 15:24:28 [updatetime] => 2024-01-11 15:24:28 [displayorder] => 0 [nrjc] => Array ( ) [nrsh] => Array ( ) [xzl] => 0 [dzl] => 0 [wailian] => https://pubmed.ncbi.nlm.nih.gov/36855941/ [demo_url] => [zjpjff] => GRADE [zjfj] => [tjqd] => [nianfen] => 2023 [guojia] => the European Society of Anaesthesiology and Intens [pdf] => [tjyjyw] => [lyyw] => Peri-operative drug-monitoring of LMWH used as standard anticoagulant in COVID-19 critical illness is suggested. If anti-Xa activity is greater than 0.3 IU/ml in clinical bleeding, reversal with protamine may be considered.（Evidence level: low；Recommendation grade: weak） [laiyuan] => 建议将低分子肝素作为新冠肺炎危重症患者的标准抗凝药物进行围手术期药物监测。如果临床出血的抗xa活性大于0.3 IU/ml，可以考虑用鱼精蛋白逆转。（证据级别：低；推荐强度：弱推荐） [znzldj] => B [_inputtime] => 1704957868 [_updatetime] => 1704957868 [_nrjc] => [_nrsh] => )
推荐意见
建议将低分子肝素作为新冠肺炎危重症患者的标准抗凝药物进行围手术期药物监测。如果临床出血的抗xa活性大于0.3 IU/ml，可以考虑用鱼精蛋白逆转。（证据级别：低；推荐强度：弱推荐）

Peri-operative drug-monitoring of LMWH used as standard anticoagulant in COVID-19 critical illness is suggested. If anti-Xa activity is greater than 0.3 IU/ml in clinical bleeding, reversal with protamine may be considered.（Evidence level: low；Recommendation grade: weak）

证据评价方法：GRADE

指南质量等级：B

年份：2023

国家：the European Society of Anaesthesiology and Intens

来源 Management of severe peri-operative bleeding: Guidelines from the European Society of Anaesthesiology and Intensive Care
原文链接
阅读

地址：甘肃省兰州市七里河区瓜州路418号

邮编：730050

电话：0931-2687109

商务合作热线：0931-2687106

备案号：陇ICP备17005383号-1 联网备案号：62010302000288

技术支持：瑞秀科技